-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »SEARCH RESULT
Total Matching Records found : 561
Dr Anand Teltumbde, Dalit intellectual, thinker and human rights activist interviewed by Prasanna D Zore
-Rediff.com On July 14, the Nagpur bench of the Bombay high court commuted the death sentence awarded to six convicts in the Khairlanji murder case to 25 years' rigorous imprisonment. On September 29, 2006, a mob brutally raped a mother and daughter before killing them along with her two sons. Surekha Bhotmange (then 42), Priyanka Bhotmange (17), Roshan Bhotmange (19) and Sudhir Bhotmange (21) belonged to one of the three Dalit families...
More »The lack of primary healthcare in India-Dr. Zeena Johar & Dr. Nachiket Mor
-The Economic Times India has some of the best quaternary and tertiary care in the world and is gradually acquiring a name for itself even in the field of 'medical tourism'. Secondary care is still a significant challenge, but even in several smaller towns and district headquarters, there is a growing supply of maternity homes and multi-speciality secondary care facilities. At all of these levels of care, given the large disease burden...
More »Plan panel wants govt to retreat from healthcare-Nitin Sethi & Kounteya Sinha
-The Times of India In a move that has angered the health ministry, the Planning Commission has asked for reversal of the long-standing public health policy from the 12th plan onwards ending governments' dominant role in providing health services and transiting to greater privatization of the health sector, something along the lines of the 'managed care' system which is followed in the US and Mexico. The health ministry has taken a tough...
More »Natco targets drugs ripe for compulsory licensing-Viswanath Pilla
-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...
More »
